Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technology Licenses PCR Technology to DuPont

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Idaho Technology said today it has a signed a licensing agreement with E.I du Pont de Nemours, more commonly known as DuPont, covering reagents and methods using Idaho Tech's Sybr Green I technology and post-PCR melting curve analysis.

The deal was reached through DuPont's Qualicon Business.

Terms of the agreement were not disclosed.

In a statement, Idaho Tech said that it extends the company's ongoing program to license "its broad and valuable intellectual property portfolio in cooperation with Roche Diagnostics." Idaho Tech licensed the rapid PCR technology from the University of Utah. It developed the LightCycler PCR-based platform and sublicensed it to Roche.

The agreement announced today took effect on June 18.

Since the start of 2009, the company has reached other licensing deals covering its PCR technology with Life Technologies Applied Biosystems business, Qiagen, Thermo Fisher Scientific, and Finnzymes, now part of Thermo Fisher.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.